Sage Journals: Discover world-class research

Open access

Research article

First published 2023-12

What clinicians need to know about intranasal esketamine for treatment-resistant depression?

Judy Hope, David Copolov, John Tiller [...]

Australasian Psychiatry

Retricted access

Research article

First published 2022-8

Intranasal esketamine for depression: Not so special K

Stephen Rosenman

Australasian Psychiatry

Open access

Research article

First published 2026

Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study

Alessandro Cuomo, Roger McIntyre, Despoina Koukouna [...]

Therapeutic Advances in Psychopharmacology

Retricted access

Research article

First published 2025-1

Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment

Luis Gutiérrez-Rojas, Julia Vendrell-Serres, J. Antoni Ramos-Quiroga [...]

Journal of Psychopharmacology

Open access

Review article

First published 2022-5

The antidepressant effect and safety of non-intranasal esketamine: A systematic review

Sanne Y Smith-Apeldoorn, Maurice Vischjager, Jolien KE Veraart [...]

Journal of Psychopharmacology

Open access

Research article

First published 2022-5

The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder

Francis M Dijkstra, Aurora JAE van de Loo, Smedra Abdulahad [...]

Journal of Psychopharmacology

Retricted access

Research article

First published 2025-01

Adjunctive Intranasal Esketamine for Comorbid Treatment-Resistant Depression with Suicidal Ideation in Patients Receiving Palliative Care at a Comprehensive Cancer Center: A Case Series

Mercy Tomy, William Alexander, Sanjay Gupta [...]

Journal of Palliative Medicine

Open access

Review article

First published 2020

Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review

Mohammed S Salahudeen, Cameron M Wright, Gregory M Peterson

Therapeutic Advances in Drug Safety

Open access

Research article

First published 2025

Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis

Ahmed Elmosalamy, Idil Tarikogullari, Liliana Patarroyo-Rodriguez [...]

Therapeutic Advances in Psychopharmacology

Retricted access

Letter

First published 2022-2

Antidepressant Effect of Prolonged Twice-Weekly Intranasal Esketamine Treatments after Nonresponse to Electroconvulsive Therapy in a Patient with Treatment-Resistant Depression

Audrey Evers, Matthew Klein, Amy Aloysi [...]

Annals of Clinical Psychiatry

Search results